US 11564937
Nucleoporins as drug targets for anti-proliferative therapeutics
granted A61KA61K31/65A61K31/7105
Quick answer
US patent 11564937 (Nucleoporins as drug targets for anti-proliferative therapeutics) held by SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
- Grant date
- Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/65, A61K31/7105, A61K35/00, A61K45/06